Member Info for comek2

The rns says they will launching in the rest of the eu market soon , eg Spain, Italy. These result so far are fantastic, without all the eu and the US, but only U.K. and Belgium. And the Middle East, where people they have a lot of money and plenty of time to shake the mattress few times a day lol. So a lot news to be released even before the full update by April. Anyone found it hard to buy around 8:30?

Good news, thanks. As I said yesterday, a deal with Space X or AD’s one alone will more than multiply tern total value. It’s a shame it’s run by Al Capone though.

Sorry ripley94, I might be thick but I don’t understand your 2 posts. Maybe cause I haven’t been following tern for sometime now.

My post below was sent incomplete. I meant to add 30% discount is completely unjustified even in this tough market for capital raising, 15% at most would have been more than enough. Is also Al Sisto personally benefitting with some brown envelopes in some tax havens island, or promised a directorship in one of the cos he intend to sell tern cheap to? AD let alone, Space X deal with Wyld will more than multiply current tern valuation. As such one would have expected a premium paid price not 30% discount. TenEleven recent involvement is a vote of confidence, having taken Darktrace to $3 billion ipo valuation. Al Sisto should change his name to Al Capone. Maybe a barrage of emails of complaint of his mishandling of both this discount but also the huge reduction in our stake he sold to TenEleven, is warranted.

This snack if deliberate destruction of shareholders value.

Oh my bad, thanks Brokeandafool. May I should check daily on my investment lol. my apologies Wanaka. So what do people make if tern now? Should ne write it off? But then Ten Eleven Ventures have just taken a significant stake, having taken Darktrace to ipo valued at £3 billions.

Ten Eleven Ventures

Wanaka, where is the evidence for your claim of the seller? Don’t you think it’s a serious statement on your part which warrant link to evidence. Some newbies might panic and sell as a result of your post and maybe to see the sp more than recover in light of the new institution shareholder who took Darktrace to £3billions IPO.

Any news/progress re Wyld and SpaceX discussion announced in August last year? That’s 5 months ago, so maybe news soon

I thought today rns was good news. Yes tern stake was reduced. But then the needed further funding eas from an investor, importantly not tern, that took darktrace to ipo valued at $3billions.

Matt le funk, silly point you make really. The share price has fallen over 900% for no reason other then bear markets affecting all smallcaps, considering the excellent progress by polx. So by your logic, we still have 800% to catch up lol

Optibiotix with similar update from 6p went up to 30p where it still is. POLX is more promising imo. The update state the product is with Philips sales team, ie it has been approved by the technical team/R&D, so news of a commercial deal could land anytime, not to mention other hospitals purchases announcements.

Polarean receives first de novo order for XENOVIEW MRI amid growing adoption

https://www.voxmarkets.co.uk/articles/polarean-receives-first-de-novo-order-for-xenoview-mri-amid-growing-adoption-07afac6

Well they have enough capital til end 2024 the rns.?considering the various hospitals & Philips that are trialling XENOVIEW they hope to have clinched some commercial deals by then. A year is long enough with these discussions & trials already going on for longer than that, so they may not need raising finance from the market. That’s how I understood the rns, reading bet the lignes. All imo

Never seen a share like this one, every time they announce a positive rns the sp goes down and by a significant %. Very weird…..unless someone is manipulating the share price for takeover, the tech being unique.

“taking bookings of SEK 41 million in this quarter. This more than doubled the order book of the whole of 2022 from SEK 32 million to SEK 73 million at the end of Q1….. At mid May the order backlog stands at SEK 91.5 million.”

https://wyldnetworks.com/directus/assets/ac46217e-e174-4b33-86a5-68c59b97f4f5

Katstrangler, Musk for fun and his ego splashed $46 billions on Twitter which has no relevance to his businesses. Wyld tech is a must for his SpaceX. Why wouldn’t he throw few $10s millions at Wyld to take it over rather be hostage to others’ fortunes?

Also Go read Wyld Q1 result, income more than double vs the whole of the year 2022…and by May 2023 it nearly tripled, results of Q2 due this month should be very interesting indeed. Yet before that we should hear developments with SpaceX, and maybe even a tweet from Musk as he likes being on the limelight. What did his tweet on doge coin do to its price, 12000% (???) in few days lol?

Dosanddonts, could you provide the link to your post please? Much appreciated

Musk likes to be in the limelight using his tweets. Expect his tweet in the form “we will soon provide internet connectivity in the most remote areas on the planet eg “Africa”, since he’s African. What did his tweet on doge coin do to the price? 10-12000%+? Can recall really

Google finance has tern up 234% this morning. Do they have a crystal ball lol?

“View from Vox

The news today builds on the announcement in June that Philips' MR 7700 MRI scanner was to be combined with XENOVIEW technology, showcasing the capability to enhance pulmonary imaging. Polarean's collaboration with a major industry player marks a significant milestone, demonstrating the wide applicability of Polarean's technology and positioning the company for increased visibility and recognition within the medical imaging market.

Polarean’s XENOVIEW 3.0T Chest Coil was cleared by the FDA in December 2022.

It’s estimated that almost 550 million people worldwide are living with chronic lung disease, demonstrating the huge demand for medical imaging to aid in early diagnosis. Providing an enhanced picture of the lungs may help a variety of patients suffering from lung diseases, which can include idiopathic pulmonary fibrosis, COPD, pulmonary hypertension, radiation therapy, cystic fibrosis and asthma.

Polarean remains well-funded, with $16.5m in the bank at the end of 2022, positioning it well to continue advancing XENOVIEW across various stages of commercialisation in the US and beyond.”

https://www.voxmarkets.co.uk/articles/polarean-receives-fda-clearance-supporting-collaboration-with-philips--3546285